A systematic review of the safety profile of levetiracetam: a new antiepileptic drug.
about
Monotherapy for partial epilepsy: focus on levetiracetamReview of levetiracetam, with a focus on the extended release formulation, as adjuvant therapy in controlling partial-onset seizuresLevetiracetam in the treatment of epilepsyEpilepsy, Antiepileptic Drugs, and Aggression: An Evidence-Based ReviewNeurobehavioral effects of levetiracetam in patients with traumatic brain injuryBrivaracetam as adjunctive therapy for the treatment of partial-onset seizures in patients with epilepsy: the current evidence baseSelf-reported feelings of anger and aggression towards others in patients on levetiracetam: data from the UK antiepileptic drug register.A new mechanism for antiepileptic drug action: vesicular entry may mediate the effects of levetiracetam.Psychiatric symptoms and quality of life in patients with drug-refractory epilepsy receiving adjunctive levetiracetam therapyLevetiracetam: treatment in epilepsy.Behavioural effects of the newer antiepileptic drugs: an update.New medication treatment options for bipolar disorders.Levetiracetam safety profiles and tolerability in epilepsy patients.Safety and tolerability of emerging pharmacological treatments for bipolar disorder.Levetiracetam in the Treatment of Epileptic Seizures After Liver TransplantationEmerging treatments for bipolar disorder: safety and adverse effect profiles.The safety of levetiracetam.Levetiracetam Extended Release as Adjuvant Therapy for the Control of Partial-onset Seizures.Levetiracetam in the treatment of childhood epilepsy.Levetiracetam for the treatment of co-occurring alcohol dependence and anxiety: case series and review.Levetiracetam use in pregnancy.Levetiracetam and pregabalin for antiepileptic monotherapy in patients with primary brain tumors. A phase II randomized study.Efficacy and safety of prophylactic levetiracetam in supratentorial brain tumour surgery: a systematic review and meta-analysis.Levetiracetam Differentially Alters CD95 Expression of Neuronal Cells and the Mitochondrial Membrane Potential of Immune and Neuronal Cells in vitro.Targeting Neural Hyperactivity as a Treatment to Stem Progression of Late-Onset Alzheimer's Disease.Neurobehavioral effects of levetiracetam in brain tumor related epilepsy.Do Antiepileptic Drugs Make Seizures Worse? A Meta-analysis.Levetiracetam Pharmacokinetics in a Patient Receiving Continuous Venovenous Hemofiltration and Venoarterial Extracorporeal Membrane Oxygenation.Single-dose pharmacokinetics of levetiracetam in healthy Chinese male subjects.The efficacy and side effects of levetiracetam on refractory epilepsy in children.Efficacy and safety of levetiracetam (up to 2000 mg/day) in Taiwanese patients with refractory partial seizures: a multicenter, randomized, double-blind, placebo-controlled study.Clinical pharmacology of levetiracetam for the treatment of epilepsy.Levetiracetam in refractory pediatric epilepsy.Evaluation of levetiracetam as adjunctive treatment for refractory canine epilepsy: a randomized, placebo-controlled, crossover trial.Clinical, cognitive, and neurophysiologic correlates of short-term treatment with carbamazepine, oxcarbazepine, and levetiracetam in healthy volunteers.Levetiracetam: a practical option for seizure management in elderly patients with cognitive impairment.Levetiracetam in patients with central neuropathic post-stroke pain--a randomized, double-blind, placebo-controlled trial.Levetiracetam has an activity-dependent effect on inhibitory transmission.Brivaracetam in the Treatment of Patients with Epilepsy-First Clinical Experiences.Synaptic vesicle protein2A decreases in amygdaloid-kindling pharmcoresistant epileptic rats.
P2860
Q24644605-E3166D51-498A-4806-9271-508D481D4A18Q24650880-C68D2EA9-DE3C-4B2B-BEC3-132727515554Q24656333-AFF5A924-E46B-4F90-8714-D1BA7F682711Q26743786-CADA5343-16D4-4479-8B4C-3E7D3BB45E10Q26830325-A4370E08-7665-4D21-88E9-D62378D1A70CQ28076065-7D7578B5-7CC4-405D-88D1-9B07908DEF0AQ30604685-6D022CA0-D16C-40EC-9B44-E12C6F453916Q35217702-69380656-469A-46E9-B100-434AC13630A9Q35539645-D312C5FD-DFDF-48AB-BAF2-CE407A269BEBQ35575012-B27D274A-C665-4EC9-BCE9-6C3DC5BFE5A0Q35609738-2265C410-268C-4B76-AED1-8A12920CD2ECQ35872066-DCD9B93F-9147-41E7-9D71-8D404E7427D1Q35873716-0961F6A8-12BE-42EA-81D1-557C406520F1Q36199036-B92E196B-78E9-4EC4-94CB-57BD1831AC9AQ36255864-3641F9B5-8B27-44F7-A69F-AC8F17B63604Q36364980-D305199B-557D-4B30-8D4D-7925857CE7DAQ36811528-27666930-240F-4D27-B0CC-4814AB11E803Q36873888-ADD84397-6384-49CC-BA8E-F7B428343DBEQ37126800-CB42C651-A29E-4952-ADBC-86CE8FACA86AQ37292504-53BA9404-1454-4CA7-9DDF-09E9BDB34711Q37582075-94DBF9EA-9285-4E70-9B3F-EB60CD8EAE3CQ37641223-1FE8AEEA-57B9-43FA-BA46-CA988EA0F5FEQ38761893-BEFDECB1-8FA6-458E-B749-F25076F7CB6CQ39237618-6D7AA41C-8746-4FDB-87AD-3AEAB1538745Q39339952-F3791DAC-3B8C-4761-B5B5-D0CEFFD4463DQ39378541-7F74F637-6F4F-4E59-B077-4D8E530B222CQ40467208-F5E9A3D8-F1C8-4FC8-9981-EF16F1B4E958Q40661074-0DDA9BFB-67E5-431E-B7F6-E2457DFCAA51Q41125106-0054152D-4E11-41BC-975D-4DFCD76002E6Q42244473-9DA37D71-F2AA-4C7C-BF3F-2FE58515DDC2Q42678199-9FA9B6C4-ED0F-4DFC-8EF5-EF62C84CAD72Q42723600-5578BA5C-A7EC-4AE8-AF45-A7BFCCBB69F1Q44099483-A67FF10E-A1DF-48BF-9EAB-2AC962C0E2E2Q44863362-AD9DB75D-FF02-4163-88C2-D6CB00CED91CQ45059187-E83ECA63-0E72-4113-AD7D-B40530251EAEQ46253104-424508A2-B584-48E3-AA6F-9596BBD9F901Q48226147-59344730-DCE2-4A1C-90B3-E8374C296E55Q48682921-11CE9CB8-6688-4636-A3D0-D6E56A74269DQ50183085-C99A6A37-26CE-435C-B775-9EE128B1BB04Q52147702-C7E30113-D01B-4907-901D-8BC887C83B75
P2860
A systematic review of the safety profile of levetiracetam: a new antiepileptic drug.
description
2001 nî lūn-bûn
@nan
2001 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
A systematic review of the safety profile of levetiracetam: a new antiepileptic drug.
@ast
A systematic review of the safety profile of levetiracetam: a new antiepileptic drug.
@en
A systematic review of the safety profile of levetiracetam: a new antiepileptic drug.
@nl
type
label
A systematic review of the safety profile of levetiracetam: a new antiepileptic drug.
@ast
A systematic review of the safety profile of levetiracetam: a new antiepileptic drug.
@en
A systematic review of the safety profile of levetiracetam: a new antiepileptic drug.
@nl
prefLabel
A systematic review of the safety profile of levetiracetam: a new antiepileptic drug.
@ast
A systematic review of the safety profile of levetiracetam: a new antiepileptic drug.
@en
A systematic review of the safety profile of levetiracetam: a new antiepileptic drug.
@nl
P1433
P1476
A systematic review of the safety profile of levetiracetam: a new antiepileptic drug
@en
P2093
P356
10.1016/S0920-1211(01)00296-0
P577
2001-11-01T00:00:00Z